Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | yes | yes: 4 |
Pissara et al. | yes | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005829 | cytosol | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Related structures:
AlphaFold database: Q4Q6Y1
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 254 | 256 | PF00675 | 0.771 |
CLV_PCSK_KEX2_1 | 248 | 250 | PF00082 | 0.769 |
CLV_PCSK_PC1ET2_1 | 248 | 250 | PF00082 | 0.766 |
CLV_PCSK_SKI1_1 | 18 | 22 | PF00082 | 0.511 |
CLV_PCSK_SKI1_1 | 264 | 268 | PF00082 | 0.500 |
CLV_PCSK_SKI1_1 | 279 | 283 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 32 | 36 | PF00082 | 0.503 |
DEG_APCC_DBOX_1 | 278 | 286 | PF00400 | 0.572 |
DEG_SCF_FBW7_2 | 155 | 161 | PF00400 | 0.866 |
DOC_CKS1_1 | 155 | 160 | PF01111 | 0.794 |
DOC_PP1_RVXF_1 | 262 | 268 | PF00149 | 0.476 |
DOC_USP7_MATH_1 | 144 | 148 | PF00917 | 0.747 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.704 |
DOC_USP7_MATH_1 | 197 | 201 | PF00917 | 0.676 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.656 |
DOC_WW_Pin1_4 | 137 | 142 | PF00397 | 0.662 |
DOC_WW_Pin1_4 | 154 | 159 | PF00397 | 0.808 |
LIG_14-3-3_CanoR_1 | 293 | 302 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 32 | 37 | PF00244 | 0.580 |
LIG_APCC_ABBA_1 | 309 | 314 | PF00400 | 0.528 |
LIG_APCC_ABBAyCdc20_2 | 298 | 304 | PF00400 | 0.540 |
LIG_APCC_ABBAyCdc20_2 | 308 | 314 | PF00400 | 0.539 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.553 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.553 |
LIG_FHA_1 | 267 | 273 | PF00498 | 0.703 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.418 |
LIG_FHA_2 | 101 | 107 | PF00498 | 0.508 |
LIG_FHA_2 | 272 | 278 | PF00498 | 0.565 |
LIG_FHA_2 | 35 | 41 | PF00498 | 0.430 |
LIG_IRF3_LxIS_1 | 41 | 46 | PF10401 | 0.575 |
LIG_LIR_Gen_1 | 204 | 213 | PF02991 | 0.597 |
LIG_LIR_Nem_3 | 204 | 208 | PF02991 | 0.617 |
LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.516 |
LIG_Pex14_2 | 11 | 15 | PF04695 | 0.389 |
LIG_SH2_CRK | 80 | 84 | PF00017 | 0.450 |
LIG_SH2_CRK | 99 | 103 | PF00017 | 0.472 |
LIG_SH2_PTP2 | 52 | 55 | PF00017 | 0.486 |
LIG_SH2_SRC | 52 | 55 | PF00017 | 0.486 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.530 |
LIG_SH3_1 | 152 | 158 | PF00018 | 0.656 |
LIG_SH3_3 | 129 | 135 | PF00018 | 0.651 |
LIG_SH3_3 | 152 | 158 | PF00018 | 0.743 |
LIG_SH3_3 | 161 | 167 | PF00018 | 0.813 |
LIG_SUMO_SIM_par_1 | 34 | 40 | PF11976 | 0.488 |
LIG_TRAF2_1 | 173 | 176 | PF00917 | 0.854 |
LIG_WRC_WIRS_1 | 105 | 110 | PF05994 | 0.508 |
LIG_WW_3 | 250 | 254 | PF00397 | 0.697 |
MOD_CK1_1 | 204 | 210 | PF00069 | 0.661 |
MOD_CK2_1 | 100 | 106 | PF00069 | 0.509 |
MOD_CK2_1 | 271 | 277 | PF00069 | 0.490 |
MOD_Cter_Amidation | 229 | 232 | PF01082 | 0.751 |
MOD_GlcNHglycan | 178 | 181 | PF01048 | 0.780 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.696 |
MOD_GlcNHglycan | 295 | 298 | PF01048 | 0.453 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.511 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.791 |
MOD_GSK3_1 | 197 | 204 | PF00069 | 0.637 |
MOD_GSK3_1 | 267 | 274 | PF00069 | 0.644 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.524 |
MOD_N-GLC_1 | 267 | 272 | PF02516 | 0.595 |
MOD_N-GLC_1 | 293 | 298 | PF02516 | 0.480 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.564 |
MOD_NEK2_1 | 266 | 271 | PF00069 | 0.640 |
MOD_NEK2_1 | 327 | 332 | PF00069 | 0.496 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.543 |
MOD_PK_1 | 70 | 76 | PF00069 | 0.532 |
MOD_PKA_1 | 231 | 237 | PF00069 | 0.755 |
MOD_PKA_1 | 255 | 261 | PF00069 | 0.731 |
MOD_PKB_1 | 253 | 261 | PF00069 | 0.684 |
MOD_PKB_1 | 68 | 76 | PF00069 | 0.502 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.675 |
MOD_Plk_4 | 327 | 333 | PF00069 | 0.530 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.604 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.663 |
MOD_ProDKin_1 | 137 | 143 | PF00069 | 0.665 |
MOD_ProDKin_1 | 154 | 160 | PF00069 | 0.805 |
MOD_SUMO_for_1 | 169 | 172 | PF00179 | 0.743 |
MOD_SUMO_rev_2 | 185 | 194 | PF00179 | 0.781 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.530 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.472 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.445 |
TRG_ER_diArg_1 | 332 | 335 | PF00400 | 0.556 |
TRG_ER_diArg_1 | 68 | 71 | PF00400 | 0.510 |
TRG_NLS_MonoExtC_3 | 150 | 155 | PF00514 | 0.658 |
TRG_NLS_MonoExtN_4 | 150 | 155 | PF00514 | 0.613 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IL25 | Leptomonas seymouri | 64% | 97% |
A0A3R7N1J6 | Trypanosoma rangeli | 37% | 87% |
A0A3S5H7N8 | Leishmania donovani | 93% | 100% |
A4HIP3 | Leishmania braziliensis | 87% | 100% |
A4I5Z0 | Leishmania infantum | 93% | 100% |
E9B183 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
V5BX42 | Trypanosoma cruzi | 38% | 81% |